首页>
外国专利>
Alirocumab or a pharmaceutically acceptable derivative thereof (PRALUENT)
Alirocumab or a pharmaceutically acceptable derivative thereof (PRALUENT)
展开▼
机译:Alirocumab或其药学上可接受的衍生物(PRALUENT)
展开▼
页面导航
摘要
著录项
相似文献
摘要
Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
展开▼